Skip to main content

H.R. 6392

Referred to Committee

No Tax Breaks for Drug Ads Act

Introduced 1/13/2022•117th Congress•House

Latest Action

Referred to the House Committee on Ways and Means.

1/13/2022 • House

Summary

No Tax Breaks for Drug Ads Act

This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.

Introduced in House • 1/13/2022

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Taxation

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (4)

Party Breakdown

4
Democrats
0
Republicans
0
Independents

Sponsor

R[
Rep. Slotkin, Elissa [D-MI-8]

Democrat • MI-8

Sponsored 1/13/2022

Cosponsors (3)

R[
Rep. Trone, David J. [D-MD-6]

D-MD-6

Joined 1/13/2022

R[
Rep. Axne, Cynthia [D-IA-3]

D-IA-3

Joined 1/14/2022

R[
Rep. Wild, Susan [D-PA-7]

D-PA-7

Joined 5/12/2022

Bill Journey

Originated in the House

Introduced

January 13, 2022

Referred to the House Committee on Ways and Means.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House1/13/2022

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors3